Introduction
My kidneys and I recently celebrated 34 years of life-a milestone that might have seemed unrealistic had I been born in a different time. It seemed out of reach for me as well until I began getting coordinated care for my cystic fibrosis (CF), a disease that has likewise spent all 34 years with me but only received proper management well into my adult years. CF is a genetic disease in which the body cannot produce, transport, and/or use a specific type of protein that helps electrolytes get across cell membranes 1 . It remains the most common fatal genetic disease among people of European heritage 2 . Surviving and beginning to thrive with my CF has thus involved reckoning with many things beyond my own mortality as a general construct. Like any other patient, I constantly engage in illness management-the process of adjusting to changes in my health and allowing them to become part of my sense of normalcy 3 . And like any other scientist, I generally begin my processes of reckoning by examining data. In this narrative, I use my experiences to (1) give an overview of scholarship related to CF and kidney disease, (2) detail my experiences managing CF and kidney disease, and (3) outline ways clinicians can better serve patients by amplifying our voices.
An Overview of Scholarship on CF and Kidney Disease
Throughout my 34 years and counting, some trends in CF survival data have remained remarkably similar. Over 80 percent of people with CF still die from respiratory failure, even if they live for many decades before their lungs eventually succumb to the ravages of the disease 4 . That leaves the other 20 percent of us who will likely still die from our CF, but from impacts to other organ systems as opposed to steep declines in lung function 5 . Kidney disease increasingly ranks among the leading causes of death for adults with CF 6 . This represents a change in the data from the early 1980s when I was born. My nephrologist here in Orlando commented that the learning curve for physicians has been just as steep as it has for patients with respect to chronic kidney disease, as only recently did people with CF begin surviving long enough in sufficient numbers to present a substantial case population.
Kidney disease is not a universal experience among people with CF, in part because so many patients continue to experience respiratory failure. The unique form of diabetes associated with CF can also harm the kidneys, but is observed in under 50 percent of the total disease population 7 . Likewise, not everyone who does develop CF related diabetes experiences kidney dysfunction as a result 8 . However, every person living with CF does experience elevated risk for renal impairment, especially as they grow older 9 . Several factors can contribute to kidney disease in people aging with CF. One prominent factor is obstruction of the glomeruli-the small ducts inside of the kidneys that transport fluids-with hardened pieces of mucus 10 . While I return to other pieces of CF or kidney disease where relevant later in the piece, these examples represent the overall picture of the intersection of these conditions in the existing scholarship. With this background in mind, I now shift to my own experiences before drawing on those experiences to make suggestions for clinicians in closing. This meant that I needed types of data that are often more difficult to find in research journals-those that amplify patient voices and experiences 14 . I knew plenty of people with double lung transplants, something that had never been on the table for me once inhaled corticosteroids had rescued my pulmonary function 15 . As I got more involved in the CF community online, I also came to know several people who had undergone successful kidney transplants. Some of them even had stories like mine-relatively classic phenotypic cases of CF that fell through the cracks in a broken health care system. My first chloride sweat tests, once the gold standard for diagnosing CF, were performed at a scant few years of age. Insufficient sweat meant no conclusive diagnosis despite concerning results, and I floundered into adulthood with a halfway managed disease playing havoc with my body. I lost upwards of 40 pounds from my slender frame that I would never find again. I lived with chronic mycobacterial pneumonia for most of my 20s. My kidneys screamed with pain daily. My legs swelled, the skin shining and painful with edema; my eyes bulged from my skull. I began to think about dialysis not as a question of "if" but rather one of "when".
Yet things slowly began to improve. Some of the news I received was bad, if not unexpected-the kidney disease diagnosis, the evidence of thickened airways, the near-total failure of my pancreas to produce digestive enzymes anymore. Other pieces of news were better-airways only mildly thickened, lung function good and increasing, no diabetes despite the exocrine pancreatic insufficiency, kidney disease present but not progressing. I learned how to manage my kidney health better-not drinking inordinate quantities of water, managing my thirst instead with a combination of good hydration practices and mucus-thinning drugs, getting my medications adjusted to avoid adverse reactions, starting on special vitamin supplements for people with CF, staying away from anything that could damage the blood vessels further.
As I felt the seeds of empowerment taking root, I thought about the stories I had heard from friends online-people living happily with their transplanted kidneys, free from dialysis and the misery of waiting between sessions. I thought doubly hard about my mantra from all those years-"I'll manage"-and wondered if perhaps that was an appropriate way of thinking now that I was no longer dying of a mysterious disease but rather living with a reasonably well understood one. I moved the goalpost accordingly-to be the oldest living person with CF, botched diagnosis and fragmented care be damned. I had learned that my genetics were not only atypical, but also likely to mean that I only had problems using the CF transmembrane conductance regulator protein rather than producing or transporting it, which likely meant my prognosis was better than those of many of my peers.
When the results from my renal ultrasound came back, I thought about those too. My nephrologist gave me a hopeful smile for the first time, saying that there was no severe damage to the tubules or other structures in my kidneys-just widespread inflammation and some light scarring. And as we continued to monitor my renal bloodwork and urine output, he said that my kidney disease did not appear to be progressing at a rapid rate. I contemplated the possibility of finishing out this life with all of my original parts, save the multiple teeth I had already lost and the gum tissue that had to be surgically reconstructed after its destruction by years of chronic infections. I still do not know if that hope will become reality for me, but I realized recently that I have come to a place in my life and health care where I can accept either alternative. I shared that with my parents in a lengthy series of text messages as if it were a small matter. Yet they knew, as I did, the seismic shift it represented in my thinking about the future.
Advice for Clinicians Serving Patients with CF and Kidney Disease
I share my experience now to highlight the importance of centering patient voices in care for kidney disease, whether related to CF or otherwise. Many people resist even discussing organ transplantation as an option because they have not gotten the opportunity to hear from recipients of successful donations 16 . Transplant can seem like an incredibly fatalistic prospect, especially for people who already know they are living with terminal diseases. The fact that your condition may take a very long time to kill you does not, I have learned, take away the fear that comes with thinking about potential kidney failure. I always said that I was not afraid to die, but rather afraid to suffer; that statement remains true for me today. I also still get regular tastes of the suffering my CF can induce with respect to renal function, from the recurrent infections that turn my urine cloudy and foul to the shooting pains from inflammation and temporary obstructions in the ducts.
Yet I have learned to think differently about suffering itself, in terms of both the potential for a successful physical outcome and the likelihood of emotional value being gained by allowing the person who gave me life to continue giving to me in that way. Perhaps most importantly, I have learned not to look at myself as a "waste" of any donated kidney I might receive, whether my mother's or a deceased person's, because of the progressive nature of my disease. After all, you do not get to be the oldest living person with CF without taking a few risks along the way-foremost among them opening your mind to things you thought you would never consider. As more adults with CF continue surviving into late life with each passing year, it will be increasingly critical for nephrology practitioners not only to understand the challenges we face with our kidney health, but to communicate with us about those struggles in ways that promote empowerment. Centering our voices in that dialogue offers a hugely impactful and readily achievable specific aim in support of that broader goal.
